By LUIS DREISBACH Similar small molecules tend to be similarly effective against disease, often sharing…
Drug discovery
Sci-fi or AI? What will a supercharged pharmaceutical industry look like?
By PAUL VON BÜNAU Fully digitised, AI-directed, in-silico drug discovery and development programs are not…
Correcting confounding biases in genome-wide association studies
By BENJAMIN HÄUSLER and RAPHAEL SCHYMCZYK Linkage disequilibrium score regression is already being put to…
Double strength: how can we better predict effective, as-yet untried, drug combinations?
By MONA SCHIRMER Some things just work better with two – but when it comes…
‘Data Science discoveries can cause a domino effect’
By HANNAH MARTIN Mona, a Student Assistant at idalab, explains why AI’s habit of turning…